InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EB Biotin | Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activa... | 2019 | Cell Rep. | de Carvalho R.V.H. et al. | DOI: 10.1016/j.celrep.2018.12.047 |
| Primocin® | Correlation of in vitro cell adhesion, local shear flow and cell density. | 2019 | RSC Adv. | Jötten A.M. et al. | DOI: 10.1039/C8RA07416J |
| Plasmocin® - Mycoplasma Elimination Reagent | Automated Detection of Autophagy Response Using Single Cell-Based Microscopy ... | 2019 | Methods Mol Biol. | Mueller A.J. & Proikas-Cezanne T. | DOI: 10.1007/978-1-4939-8873-0_27 |
| PlasmoTest™ - Mycoplasma Detection Kit | SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. | 2019 | Nat Commun. | Yuan S. et al. | DOI: 10.1038/s41467-018-08015-x |
| Puromycin | The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism a... | 2019 | Oncogene | Parzych K. et al. | DOI: 10.1038/s41388-018-0651-z |
| EndoFit™ OVA protein | Corn-derived alpha-D-glucan nanoparticles as adjuvant for intramuscular and i... | 2019 | Nanomedicine. | Dhakal S. et al. | DOI: 10.1016/j.nano.2018.12.003 |
| R848 (Resiquimod) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Normocin® - Antimicrobial Reagent | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Imiquimod VacciGrade™ (R837) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Imiquimod (R837) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| QUANTI-Blue™ | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| R848 VacciGrade™ | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| ASC-GFP Reporter Monocytes | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Poly(I:C) (LMW) / LyoVec™ | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| MDP | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Poly(dA:dT) | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| MSU Crystals | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| ATP | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Bafilomycin A1 | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |